Identification Generic Name (2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate DrugBank Accession Number DB07592 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate (DB07592) ×  Close Weight Average: 305.4119  Monoisotopic: 305.199093735  Chemical Formula C 18 H 27 NO 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Cathepsin K Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Not Available Direct Parent Benzene and substituted derivatives Alternative Parents Carbamate esters  /  Organic carbonic acids and derivatives  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Aldehydes Substituents Aldehyde  /  Aromatic homomonocyclic compound  /  Carbamic acid ester  /  Carbonic acid derivative  /  Carbonyl group  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key ZLZXUNHJWVLGTE-DLBZAZTESA-N InChI InChI=1S/C18H27NO3/c1-4-5-11-16(13-20)19-18(21)22-17(14(2)3)12-15-9-7-6-8-10-15/h6-10,13-14,16-17H,4-5,11-12H2,1-3H3,(H,19,21)/t16-,17+/m0/s1 IUPAC Name (2R)-3-methyl-1-phenylbutan-2-yl N-[(2S)-1-oxohexan-2-yl]carbamate SMILES [H][C@@](CCCC)(NC(=O)O[C@]([H])(CC1=CC=CC=C1)C(C)C)C=O References General References Not Available External Links PubChem Compound 10062713 PubChem Substance 99444063 ChemSpider 8238256 BindingDB 50148298 ChEMBL CHEMBL113948 ZINC ZINC000027083677 PDBe Ligand CT1 PDB Entries 2aux Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00958 mg/mL ALOGPS logP 3.7 ALOGPS logP 4.43 Chemaxon logS -4.5 ALOGPS pKa (Strongest Acidic) 14.08 Chemaxon pKa (Strongest Basic) -7.3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 55.4 Å 2 Chemaxon Rotatable Bond Count 10 Chemaxon Refractivity 87.15 m 3 ·mol -1 Chemaxon Polarizability 34.79 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9596 Caco-2 permeable + 0.5965 P-glycoprotein substrate Non-substrate 0.5597 P-glycoprotein inhibitor I Non-inhibitor 0.5504 P-glycoprotein inhibitor II Non-inhibitor 0.763 Renal organic cation transporter Non-inhibitor 0.9176 CYP450 2C9 substrate Non-substrate 0.7593 CYP450 2D6 substrate Non-substrate 0.7677 CYP450 3A4 substrate Substrate 0.5354 CYP450 1A2 substrate Inhibitor 0.5797 CYP450 2C9 inhibitor Non-inhibitor 0.764 CYP450 2D6 inhibitor Non-inhibitor 0.8863 CYP450 2C19 inhibitor Inhibitor 0.562 CYP450 3A4 inhibitor Non-inhibitor 0.8051 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7562 Ames test Non AMES toxic 0.8349 Carcinogenicity Non-carcinogens 0.8448 Biodegradation Not ready biodegradable 0.7995 Rat acute toxicity 2.3964 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9511 hERG inhibition (predictor II) Non-inhibitor 0.9291    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 0.5 N/A N/A A30881  /  A30882 
 
 
  Details 
 
 
   Binding Properties 1.  Cathepsin K Kind Protein Organism Humans Pharmacological action Unknown General Function Proteoglycan binding Specific Function Closely involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an i... Gene Name CTSK Uniprot ID P43235 Uniprot Name Cathepsin K Molecular Weight 36965.82 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:23 / Updated at June 12, 2020 16:52 